Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Panel Attempts Thrombosis Prevention In Taxus Labeling, Clears Seven Sizes

This article was originally published in The Gray Sheet

Executive Summary

Labeling for Boston Scientific'sTaxus paclitaxel-eluting stent should highlight the need for patients to take an anti-platelet and aspirin regimen for the first six months to prevent blood clots, FDA's Circulatory System Devices Panel recommends

You may also be interested in...



Taxus Breezes Through Panel On Cypher Drag, Possibly Raising Data Bar

The FDA Circulatory System Devices Panel endorsed Boston Scientific's proposed ARRIVE 2,000-patient, five-year Taxus postmarket study with no additional conditions beyond proposals made by the company

Taxus Breezes Through Panel On Cypher Drag, Possibly Raising Data Bar

The FDA Circulatory System Devices Panel endorsed Boston Scientific's proposed ARRIVE 2,000-patient, five-year Taxus postmarket study with no additional conditions beyond proposals made by the company

Thrombosis Events May Be Clarified By e-CYPHER Data Expected In February

FDA's public health notification related to adverse events for J&J/Cordis' Cypher is intended to generate further data collection for the drug-eluting stent rather than raise undue concern over clotting issues, the agency says

UsernamePublicRestriction

Register

LL1133148

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel